ASCO 2019: High-risk prostate cancer: 10 year results after image guided intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost

Christian Ekanger | ASCO 2019 | 3. Juni 2019

Speaker: Christian Ekanger

10 year results show that high-risk prostate cancer patients treated with image guided intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost obtained favorable outcomes with few serious side effects. Hear Christian Ekanger present the results.